Proteomic Analysis of Chronic Pancreatitis and Pancreatic Adenocarcinoma
Tatjana Crnogorac‐Jurcevic(Queen Mary University of London), Nicholas R. Lemoine(Queen Mary University of London), Makoto Sunamura(Cancer Research UK), Teresa A. Brentnall(University of Washington), John P. Neoptolemos(University of Liverpool), Wendy Prime(University of Liverpool), Masanori Akada(Cancer Research UK), Gabriele Capurso(Vita-Salute San Raffaele University), Fiona Campbell(University of Birmingham), Rathi Gangeswaran(Cancer Research UK), Vipul Bhakta(Cancer Research UK), Samuel Lattimore(Cancer Research UK), Eithne Costello(University of Liverpool)
Cited by 175
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k